1. Search Result

Search Result

Results for "1826843-81-5" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-138298
    Trastuzumab deruxtecan

    DS-8201; DS-8201a

    EGFR Cancer
    Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, and a topoisomerase I inhibitor. Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.